- •Uveitis
- •Foreword
- •Preface
- •Dedication
- •Acknowledgments
- •Elements of the Immune System and Concepts of Intraocular Inflammatory Disease Pathogenesis
- •Elements of the immune system
- •Macrophages/monocytes
- •Dendritic cells
- •T cells
- •Major subsets of T cells
- •Cytokines
- •T-cell subsets
- •T-regulatory cells
- •T-cell receptor
- •Chemokines
- •Thymic expression and central immune tolerance
- •B cells
- •Classes of Immunoglobulin
- •Other cells
- •Mast Cells
- •Eosinophils
- •Neutrophils
- •Resident Ocular Cells
- •Complement system
- •Cellular interactions: hypersensitivity reactions
- •Classic immune hypersensitivity reactions
- •Type I
- •Type II
- •Type III
- •Type IV
- •Type V
- •Concepts of disease pathogenesis
- •Immune characteristics of the eye
- •Absence of lymphatic drainage
- •Intraocular microenvironment
- •Anterior Chamber-Associated Immune Deviation (ACAID)
- •Fas-Fas Ligand Interactions and Programmed Cell Death (Apoptosis)
- •Resident Ocular Cells and Immune System
- •Cytokines and Chemokines and the Eye
- •Oral Tolerance
- •Choroidal circulation and anatomy
- •Retina
- •Immunogenetics
- •Class I antigens
- •Class II and class III antigens
- •Histocompatibility lymphocyte antigens
- •Single-nucleotide polymorphisms (SNPs)
- •Epigenetics
- •Immune complex-mediated disease
- •Gene expression profiling
- •Tissue damage in the eye
- •T-cell responses and autoimmunity
- •T-cell receptor and the expression of disease
- •Ocular autoimmunity
- •Uveitogenic antigens
- •Retinal S-Antigen (Arrestin)
- •Interphotoreceptor Retinoid-Binding Protein
- •Recoverin
- •Bovine Melanin Protein
- •Rhodopsin
- •Phosducin
- •Tyrosinase
- •Other Antigens
- •Endotoxin and Other Bacterial Antigens
- •Importance of Antigen Studies
- •Cell adhesion molecules and their role in lymphocyte homing and in disease
- •Immune responses to invading viruses and parasites
- •Suggested Readings
- •References
- •Medical History in the Patient with Uveitis
- •References
- •Sample Uveitis Questionnaire
- •FAMILY HISTORY
- •SOCIAL HISTORY
- •PERSONAL MEDICAL HISTORY
- •MEDICAL HISTORY
- •Examination of the Patient with Uveitis
- •Visual acuity
- •External examination
- •Pupils and extraocular muscles
- •Intraocular pressure measurement
- •Slit-lamp biomicroscopy
- •Conjunctiva
- •Cornea
- •Keratic Precipitates
- •Other Corneal Findings
- •Anterior chamber
- •Iris
- •Anterior chamber angle
- •Lens
- •Vitreous
- •Retina and choroid
- •Optic nerve
- •References
- •Development of a Differential Diagnosis
- •Forming a differential diagnosis
- •Classifying uveitis
- •Is the disease acute or chronic?
- •Is the inflammation granulomatous or nongranulomatous?
- •Is the disease unilateral or bilateral?
- •Where is the inflammation located in the eye?
- •What are the demographics of the patient?
- •What associated symptoms does the patient have?
- •What associated signs are present on physical examination?
- •What is the time course of the disease and response to previous therapy?
- •Case 4-1
- •Case 4-2
- •References
- •Diagnostic Testing
- •Pretest likelihood of disease
- •Receiver operating characteristic (ROC) curve
- •Diagnostic tests for uveitis
- •Laboratory tests
- •Image analysis
- •Skin testing
- •Tissue samples
- •Ancillary ophthalmic tests
- •Electrophysiology
- •Laser interferometry
- •Fluorescein angiography
- •Indocyanine green
- •Laser flare photometry
- •Optical coherence tomography
- •High-frequency ultrasound biomicroscopy and multifrequency ultrasound
- •Fundus autofluorescence
- •Other diagnostic tests
- •Polymerase chain reaction (PCR)
- •Rapid tests for herpes simplex and herpes zoster
- •Bone mineral density studies
- •Genetic testing for steroid-induced glaucoma
- •Neurologic tests
- •References
- •Evidence-Based Medicine in Uveitis
- •Study design
- •Clinical trials in uveitis
- •References
- •Philosophy, Goals, and Approaches to Medical Therapy
- •Goals and philosophy
- •Pain, photophobia, and discomfort
- •Degree and location of inflammatory disease
- •Evaluation of visual acuity and prospect of reversibility
- •Follow-up procedures and standardization of observations
- •General health and age of patient
- •Patient reliability, preferences, and understanding
- •Nonsurgical therapeutic options
- •Corticosteroids
- •Mode of Action
- •Preparations, Dosage Schedules, and Complications
- •Ozurdex.
- •Secondary Effects
- •Cytotoxic agents
- •Alkylating agents
- •Mode of Action
- •Indications and Dosages
- •Secondary Effects
- •Antimetabolites
- •Azathioprine
- •Mode of Action
- •Indications and Dosages
- •Secondary Effects
- •Mycophenolate mofetil
- •Methotrexate
- •Mode of Action
- •Indications and Dosages
- •Secondary Effects
- •Ciclosporin
- •Mode of Action
- •Dosages and Indications
- •Secondary Effects
- •Tacrolimus
- •Mode of Action
- •Indications and Dosages
- •Secondary Effects
- •Lx 211 (Voclosporin)
- •Rapamycin
- •Mode of Action
- •Indications and Dosages
- •Toxicity
- •Antibodies and monoclonal antibodies
- •Daclizumab
- •Etanercept
- •Infliximab (Remicade)
- •Adalimumab (Humira)
- •Efalizumab (Raptiva)
- •Rituximab (Rituxan)
- •Anakinra (Kineret)
- •Alemtuzumab (Campath-1H)
- •Abatacept (Orencia)
- •Intravenous immunoglobulin therapy
- •Oral tolerance
- •Interferon-α
- •Antiviral therapy
- •Aciclovir
- •Ganciclovir
- •Valaciclovir
- •Famciclovir
- •Foscarnet
- •Combined ganciclovir and foscarnet
- •Cidofovir
- •Fomivirsen
- •Colchicine
- •Mode of Action
- •Indications and Dosages
- •Secondary Effects
- •Mydriatic and cycloplegic agents
- •Antitoxoplasmosis therapy
- •Other therapeutic approaches
- •Immunostimulators
- •Plasmapheresis
- •Nonsteroidal antiinflammatory agents
- •References
- •Role of Surgery in the Patient with Uveitis
- •Considerations
- •Removal of band keratopathy
- •Corneal transplantation
- •Cataract surgery
- •Glaucoma surgery
- •Treatment of vitreoretinal disease
- •Laser treatment
- •Photodynamic therapy
- •Diagnostic surgery
- •Anterior chamber paracentesis
- •Chorioretinal biopsy
- •Subretinal surgery
- •Case 8-1
- •References
- •Bacterial and Fungal Diseases
- •Introduction
- •Leprosy
- •Clinical findings
- •Immunology and pathology
- •Therapy
- •Tuberculosis
- •Systemic disease
- •Ocular disease
- •Diagnosis
- •Therapy
- •Other bacterial infections
- •Brucellosis
- •Whipple’s disease
- •Treatment and prognosis
- •Chronic granulomatous disease
- •Fungal disease
- •Neuroretinitis
- •References
- •Spirochetal Diseases
- •Spirochetal infections and the eye
- •Spirochetes
- •Definition
- •Venereal treponemal diseases
- •Syphilis
- •Etiology and Epidemiology
- •Clinical Manifestations
- •Primary syphilis.
- •Secondary syphilis.
- •Latent syphilis.
- •Tertiary syphilis.
- •Benign tertiary syphilis.
- •Cardiovascular syphilis.
- •Neurosyphilis.
- •Congenital syphilis.
- •Ocular Manifestations
- •Diagnosis
- •Prognosis
- •Treatment
- •General recommendations.
- •Approach to Syphilis in Patients with AIDS
- •Nonvenereal treponematoses
- •Endemic syphilis
- •Etiology and Epidemiology
- •Clinical Manifestations
- •Ocular Manifestations
- •Diagnosis
- •Prognosis
- •Treatment
- •Yaws and pinta
- •Ocular Manifestations
- •Diagnosis
- •Prognosis
- •Treatment
- •Borrelia infection
- •Lyme disease
- •Etiology and Epidemiology
- •Clinical Manifestations
- •Ocular Manifestations
- •Diagnosis
- •Prognosis
- •Treatment
- •Relapsing fever
- •Etiology and Epidemiology
- •Clinical Manifestations
- •Ocular Manifestations
- •Diagnosis
- •Prognosis
- •Treatment
- •Leptospirosis
- •Etiology and Epidemiology
- •Clinical Manifestations
- •Ocular Manifestations
- •Weil’s disease
- •Diagnosis
- •Prognosis
- •Treatment
- •Case 10-1
- •References
- •Acquired Immunodeficiency Syndrome
- •Human immunodeficiency virus
- •Epidemiology
- •Diagnosis
- •HIV disease
- •HIV therapy
- •Ocular manifestations of HIV infection
- •Ocular infection
- •Cytomegalovirus retinitis
- •Progression
- •CMV retinitis in the era of highly active antiretroviral therapy
- •Treatment
- •Intravitreal ganciclovir implant
- •Current therapeutic approach to CMV retinitis in the era of HAART
- •Retinal detachment
- •Prognosis
- •Immune recovery uveitis
- •Herpes zoster
- •Pneumocystis jirovecii choroiditis
- •Mycobacterium avium-intracellulare choroiditis
- •Other diseases
- •Drug-related ocular inflammation
- •Case 11-1
- •Case 11-2
- •References
- •Acute retinal necrosis
- •Epidemiology
- •Clinical features
- •Etiology
- •Differential diagnosis
- •Therapy
- •Progressive outer retinal necrosis
- •Diagnosis
- •Differential diagnosis
- •Etiology
- •Therapy
- •Case 12-1
- •Case 12-2
- •References
- •Other Viral Diseases
- •Herpes simplex virus kerititis and keratouveitis
- •Pathogenesis
- •Diagnosis
- •Treatment
- •Herpes zoster ophthalmicus
- •Treatment
- •West Nile virus
- •Epidemiology
- •Diagnosis
- •Clinical description
- •Ophthalmic manifestations
- •Treatment
- •Prognosis
- •Other viral infections
- •Human T-lymphotropic virus type I
- •Case 13-1
- •References
- •Ocular Toxoplasmosis
- •Organism
- •Clinical manifestations
- •Systemic
- •Ocular
- •Decreased Vision
- •Loss of Vision
- •Effects in immunocompromised host
- •Histopathology and immune factors
- •Immune response
- •Inflammatory response
- •Methods of diagnosis
- •Pregnancy
- •Other methods
- •Congenital versus acquired disease
- •Therapy
- •Additional therapeutic approaches
- •Case 14-1
- •Case 14-2
- •Case 14-3
- •Case 14-4
- •References
- •Ocular Histoplasmosis
- •Systemic findings
- •Ocular appearance
- •‘Histo’ spots
- •Maculopathy
- •Peripapillary pigment changes
- •Clear vitreous
- •Etiology and immunology
- •Nonsurgical therapies
- •Laser therapy
- •Subretinal surgery
- •References
- •Toxocara canis
- •Ocular manifestations
- •Histopathology and immune factors
- •Enzyme-linked immunoabsorbent assay
- •Treatment
- •Case 16-1
- •References
- •Onchocerciasis and Other Parasitic Diseases
- •Onchocerciasis
- •Clinical appearance
- •Immune characteristics
- •Therapy
- •Giardiasis
- •Ophthalmomyiasis
- •Cysticercosis
- •Caterpillar hairs
- •Amebiasis
- •Diffuse unilateral subacute neuroretinitis (DUSN)
- •Malaria
- •Seasonal hyperacute panuveitis (SHAPU)
- •References
- •Postsurgical Uveitis
- •Acute bacterial endophthalmitis
- •Chronic bacterial endophthalmitis
- •Fungal endophthalmitis
- •Endogenous endophthalmitis
- •Lens-induced uveitis
- •Toxic anterior segment syndrome (TASS)
- •Laser-induced uveitis
- •Case 18-1
- •References
- •Anterior Uveitis
- •Epidemiology
- •Clinical description
- •Idiopathic anterior uveitis
- •Diagnostic workup
- •Treatment
- •HLA-B27–associated anterior uveitis
- •Epidemiology
- •Demographics and clinical findings
- •Etiology
- •HLA-B27–associated anterior uveitis with systemic disease
- •Ankylosing spondylitis
- •Etiology
- •Treatment
- •Reactive arthritis (Reiter’s syndrome)
- •Juvenile idiopathic arthritis
- •Diagnosis
- •Pathology
- •Differential diagnosis
- •Treatment and prognosis
- •Psoriatic arthropathy
- •Inflammatory bowel disease
- •Whipple’s disease
- •Disease associations
- •Fuchs’ heterochromic iridocyclitis
- •Etiology
- •Treatment and prognosis
- •Kawasaki disease
- •Tubulointerstitial nephritis and uveitis syndrome (TINU)
- •Pathogenesis
- •Glaucomatous cyclitic crisis
- •Schwartz syndrome
- •Anterior segment ischemia
- •Lens-induced uveitis
- •Anterior uveitis associated with AIDS
- •Other disease associations
- •References
- •Scleritis
- •Episcleritis
- •Scleritis
- •Disease associations
- •Other causes of scleritis
- •Diagnostic testing
- •Pathogenesis
- •Differential diagnosis
- •Treatment
- •References
- •Intermediate Uveitis
- •Epidemiology
- •Clinical manifestations
- •Prognosis
- •Differential diagnosis
- •Multiple sclerosis
- •Etiology
- •Treatment
- •Corticosteroids
- •Immunosuppressive agents
- •Surgery
- •Case 21-1
- •Case 21-2
- •References
- •Sarcoidosis
- •Epidemiology
- •Etiology
- •Clinical manifestations
- •Anterior uveitis
- •Posterior segment findings
- •Systemic involvement
- •Pathology
- •Diagnosis
- •Treatment
- •Case 22-1
- •References
- •Sympathetic Ophthalmia
- •Clinical appearance and prevalence
- •Classic presentation
- •Sequelae
- •Tests and immunologic characteristics
- •Dalen–fuchs nodules
- •Preservation of the choriocapillaris
- •Therapy
- •Corticosteroids
- •Immunosuppressive agents
- •Case 23-1
- •Case 23-2
- •References
- •Vogt–Koyanagi–Harada Syndrome
- •Clinical aspects
- •Systemic findings
- •Ocular findings
- •Course of disease
- •Laboratory tests, etiology, and histopathology
- •Antigen-specific and immune responses
- •Vogt–Koyanagi–Harada syndrome versus sympathetic ophthalmia
- •Therapy
- •Cataract extraction
- •Case 24-1
- •Case 24-2
- •References
- •Birdshot Retinochoroidopathy
- •Clinical manifestations
- •Ocular examination and ancillary clinical tests
- •Tests, histology and etiology
- •Therapy
- •Case 25-1
- •Case 25-2
- •References
- •Behçet’s Disease
- •Clinical manifestations
- •Oral aphthous ulcers
- •Skin lesions
- •Genital ulcers
- •Ocular disease
- •Retinal disease
- •Complications
- •Minor criteria
- •Arthritis
- •Vascular alterations
- •Neurologic involvement (neuro-Behçet’s disease)
- •Immunologic and histologic considerations
- •Role of T cells (but other cells count too!)
- •HLA typing and single nucleotide polymorphisms (SNPs)
- •Therapy
- •Systemic corticosteroids
- •Cytotoxic and antimetabolic agents
- •Colchicine
- •Interferon-α
- •Ciclosporin and tacrolimus (FK506)
- •Anti-TNF therapy (infliximab)
- •Other approaches
- •Case 26-1
- •Case 26-2
- •Case 26-3
- •References
- •Retinal Vasculitis
- •Clinical characteristics
- •Ocular vasculitic disorders without systemic disease
- •Eales’ disease
- •Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN syndrome)
- •Frosted branch angiitis
- •Scleritis
- •Ocular vasculitic disorders with systemic disease
- •Systemic lupus erythematosus
- •Polyarteritis nodosa
- •Wegener’s granulomatosis
- •Whipple’s disease
- •Inflammatory bowel disease
- •Autoantibodies to Sjögren’s syndrome A antigen
- •Retinal vein occlusion
- •Relapsing polychondritis
- •Viral diseases
- •Multiple sclerosis
- •Tuberculosis
- •Rheumatoid arthritis
- •Kikuchi–Fujimoto disease
- •Susac syndrome
- •Sweet syndrome
- •References
- •Serpiginous Choroidopathy
- •Clinical features
- •Pathology
- •Etiology
- •Differential diagnosis
- •Therapy
- •Case 28-1
- •Case 28-2
- •Case 28-3
- •References
- •White-Dot Syndromes
- •Multiple evanescent white-dot syndrome
- •Clinical findings
- •Laboratory findings
- •Therapy
- •Multifocal choroiditis and panuveitis
- •Clinical findings
- •Punctate inner choroidopathy
- •Laboratory findings
- •Therapy
- •Acute retinal pigment epitheliitis
- •Clinical findings
- •Laboratory findings
- •Therapy
- •Acute posterior multifocal placoid pigment epitheliopathy
- •Clinical findings
- •Etiology
- •Therapy
- •Subretinal fibrosis and uveitis syndrome
- •Clinical findings
- •Laboratory findings
- •Therapy
- •Acute zonal occult outer retinopathy (AZOOR) and the azoor complex diseases
- •Case 29-1
- •Case 29-2
- •Case 29-3
- •References
- •Masquerade Syndromes
- •Intraocular lymphoma
- •Non-Hodgkin’s lymphoma of central nervous system
- •Diagnosis
- •Treatment
- •Systemic Non-Hodgkin’s lymphoma metastatic to eye
- •Lymphoid hyperplasia of uvea
- •Other malignant processes manifesting as uveitis
- •Paraneoplastic syndromes
- •Multiple sclerosis
- •Other nonmalignant conditions
- •References
- •Introduction
- •Age-related macular degeneration
- •Animal work
- •Animal laser model
- •Ccl2 and Ccr2 knockout model
- •Ccl2 and Cx3cr1 double knockout model
- •CEP induced AMD-like disease
- •Human data
- •Autoimmunity
- •Gene associations
- •Macrophages and other cells
- •Histopathology
- •The downregulatory immune environment
- •Should we consider immunotherapy?
- •Diabetic retinopathy
- •Diabetes and the immune process
- •Animal work
- •Human observations
- •Can we begin to think about immune therapy for diabetes and diabetic retinopathy?
- •Glaucoma
- •Autoantibodies and glaucoma
- •Cellular immunity and glaucoma
- •Can immune intervention help alter the course of glaucoma?
- •References
- •Index
Part 4 • Infectious Uveitic Conditions
Chapter 10 Spirochetal Diseases
Neurosyphilis. This condition is said to occur in 5–10% of |
Congenital syphilis is preventable with proper treatment of |
|
untreated patients with syphilis. Asymptomatic neurosyphi- |
the mother; therefore, all expectant mothers should have a |
|
lis is found in some patients who have a positive CSF Vene- |
VDRL test at the beginning and near the end of pregnancy. |
|
real Disease Research Laboratory (VDRL) test result but |
In fact, screening at the time of delivery is now mandatory |
|
no symptoms of central nervous system (CNS) disease. In |
in the State of New York.5 |
|
addition, invasion of the CNS by T. pallidum may be more |
Signs and symptoms of early congenital syphilis may not |
|
common in early syphilis than once thought. Lukehart and |
appear until several days after birth, and Dorfman and |
|
colleagues15 isolated T. pallidum from the CSF in 12 of 40 |
Glaser17 stated that the diagnosis of congenital syphilis may |
|
(30%) patients with untreated primary and secondary syphi- |
be missed if serologic tests are not performed for both the |
|
lis, and an additional four patients, in whom no T. pallidum |
mother and her infant at the time of delivery. A generalized |
|
was isolated, had reactive CSF on the VDRL test. Neurosyphi- |
rash develops and resembles the rash of secondary syphilis, |
|
lis can occur at any time in the course of the disease. Uveitis |
except that in the infant the rash may be vesicular or bullous. |
|
and hearing loss are more common in the earlier stages.15a |
Rhinitis (also called the snuffles), jaundice, hepatospleno |
|
One type of neurosyphilis, meningovascular syphilis, |
megaly, anorexia, and pseudoparalysis may also be found. |
|
presents as an aseptic meningitis that can occur at any time |
Osteochondritis and pathologic fractures are common, and |
|
after primary syphilis. Unilateral or bilateral cranial nerve |
radiographic changes on bone films are present in more than |
|
palsies are common, and headache, neck stiffness, dizziness, |
90% of patients. Chorioretinitis is often evident in the first |
|
lassitude, and blurred vision occur. The classic neuro- |
few months of life. |
|
ophthalmic finding of neurosyphilis is the Argyll Robertson |
Congenital syphilis may mimic other congenital infec- |
|
pupil.16 This is a small, irregular pupil that is unreactive to |
tions, such as rubella, cytomegalovirus infection, and toxo- |
|
light but normally reactive to accommodation; it is com- |
plasmosis. A positive serologic test result for syphilis may be |
|
monly seen in cases of meningovascular syphilis in which |
caused by passive transfer of antibody from the mother; |
|
the base of the brain is involved. If the spinal cord is involved |
therefore, diagnosis of congenital syphilis is based on a posi- |
|
patients may experience bulbar symptoms, muscle weakness |
tive fluorescent treponemal antibody absorption (FTA-ABS) |
|
and wasting, and slowly progressive spastic paraplegia with |
test and a rising VDRL titer. Results of serologic tests per- |
|
bladder incontinence. |
formed in infants and their mothers may be negative at the |
|
T. pallidum may also invade the substance of the brain. |
time of delivery if syphilis is acquired toward the end of the |
|
Parenchymatous neurosyphilis is a meningoencephalitis |
pregnancy. |
|
with progressive loss of cortical function. Patients can experi- |
After 2 years the child is described as having late congeni- |
|
ence altered mental status and even syphilitic psychosis, |
tal syphilis. Like syphilis in adults, late congenital syphilis |
|
with irritability, reduced memory, poor judgment, confu- |
may remain latent with few sequelae, although cardiovascu- |
|
sion, and delusions. Seizures may occur. On neurologic |
lar involvement does occur, and meningovascular syphilis |
|
examination patients demonstrate tremors of the mouth and |
with neurologic manifestations, including eighth cranial |
|
tongue, hyperreflexia, and in some cases extensor plantar |
nerve deafness, is common. Acute syphilitic meningitis, gen- |
|
responses. Pathologically, the brain parenchyma is infil- |
eralized paresis, and tabes dorsalis are less common. Inter- |
|
trated with spirochetes, and the meninges are inflamed and |
stitial keratitis is the classic ophthalmic sign of congenital |
|
thickened. The CSF is hypercellular and has a positive VDRL |
syphilis, occurring in 10% of patients. |
|
test result. Cranial nerve palsies, however, are uncommon, |
Deformities of the permanent teeth occur after early syph- |
|
and optic atrophy is rare. Although pupillary abnormalities |
ilitic infection. The characteristic Hutchinson teeth are |
|
may be seen, a complete Argyll Robertson pupil is not char- |
notched, thin, upper incisors with abnormal spacing. Hutch- |
|
acteristic. Neurosyphilis should still be considered in the |
inson’s triad is the occurrence of Hutchinson’s teeth, inter- |
|
differential diagnosis of advanced neurologic disease with |
stitial keratitis, and deafness, but the occurrence of all three |
|
generalized paresis, although this finding is rare in the |
in the same patient is unusual. The bone lesions of early |
|
United States. |
congenital syphilis tend to progress in late congenital syphi- |
|
Tabes dorsalis is a form of neurosyphilis with involve- |
lis, with the development of syphilitic arthritis. Finally, |
|
ment of the posterior columns and the posterior roots of |
gummas may develop in the subcutaneous tissue and |
|
the spinal cord, resulting in pain, ataxia, sensory changes, |
produce ulcerative skin lesions. |
|
reduced tendon reflexes, and ocular findings. Severe stabbing |
Ocular Manifestations |
|
pain in the lower extremities heralds this form of neurosyph- |
||
|
||
ilis. Unsteadiness and a wide-based gait develop later, fol- |
Table 10-1 lists some of the more common eye manifesta- |
|
lowed by hyperesthesia and paresthesia. Incontinence and |
tions of the different stages of syphilis. Ophthalmic mani- |
|
impotence are other common sequelae. Charcot’s arthropa- |
festations of primary syphilis are limited to chancres of the |
|
thy occurs in large joints devoid of sensation that are prone |
eyelid and the conjunctiva. A primary syphilitic lesion in the |
|
to destructive changes. Argyll Robertson pupils are frequent |
lacrimal gland is extremely rare but has been reported.18 |
|
in this form of neurosyphilis, and optic atrophy is com- |
The eyelids are commonly involved in the rash of second- |
|
monly found. |
ary syphilis, and blepharitis and loss of lashes and eyebrows |
|
|
are common. Conjunctivitis mimicking trachoma has also |
|
Congenital syphilis. Congenital syphilis results from the |
been seen in secondary syphilis, but dacryocystitis and |
|
transplacental transmission of T. pallidum from the mother |
dacryoadenitis are rare. Keratitis, iris nodules (Fig. 10-1), |
|
to the fetus. Untreated primary or secondary syphilis is |
iridocyclitis, episcleritis, and scleritis have all been reported |
|
almost invariably transmitted to the fetus, whereas transmis- |
in secondary syphilis. Late in the secondary stage, chorio |
|
sion in later stages of the disease occurs less frequently. |
retinitis and vitritis may develop (Fig. 10-2A). A diffuse |
144
Table 10-1 Ocular manifestations of syphilis
PRIMARY SYPHILIS
Chancres of the eyelid and conjunctiva
SECONDARY SYPHILIS
Blepharitis
Madarosis
Conjunctivitis
Dacryocystitis
Dacryoadenitis
Keratitis
Iris nodules
Iridocyclitis
Episcleritis
Scleritis
Chorioretinitis
Vitritis
Neuroretinitis
Disc edema
Exudative retinal detachment
Perivasculitis
TERTIARY SYPHILIS
Gummas of the eyelids
Unilateral interstitial keratitis
Punctate stromal keratitis
Bilateral periostitis of the orbital bone
Episcleritis
Scleritis
Anterior and posterior uveitis
Chorioretinitis
Vasculitis
Venous and arterial occlusive disease
Exudative retinal detachment
Macular edema
Neuroretinitis
Vitritis
Pseudoretinitis pigmentosa
Chorioretinal neovascular membrane
Lens dislocation
Argyll Robertson pupil
Oculomotor palsies
CONGENITAL SYPHILIS
Bilateral interstitial keratitis
Pigmentary retinitis
Glaucoma
Keratouveitis
Figure 10-1. Iris nodule caused by syphilis. (From Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. N Engl J Med 1984; 310: 972–81.)
Spirochetes
neuroretinitis may occur and is often localized to the peripapillary area.19 This is followed by a pigmentary retino pathy similar in appearance to retinitis pigmentosa. Disc edema (Fig. 10-3), exudative retinal detachment, and perivasculitis are less common findings.20–22
The gummas of tertiary syphilis can involve the eyelids, and if extensive can cause destructive ulceration, but gummatous dacryoadenitis and infiltration of the lacrimal sac have only rarely been reported. Conjunctival vascular changes occur, but gummas of the conjunctiva almost never occur. As seen in secondary syphilis, syphilitic blepharitis with madarosis is common. A diffuse bilateral periostitis is the most common orbital finding of tertiary syphilis. Uniocular interstitial keratitis is the most common corneal finding in tertiary syphilis, but punctate stromal keratitis can occur with iritis. Episcleritis and scleritis occur, but discrete gummas of the sclera are rare. Uveitis is a common finding in late tertiary syphilis. Halperin and colleagues23 stated that the main posterior segment complications of acquired syphilis include chorioretinitis, vasculitis, venous and arterial occlusive disease, retinal detachment with choroidal effusion, macular edema, neuroretinitis, optic neuritis, vitritis (Fig. 10-2A), and pseudoretinitis pigmentosa (Fig. 10-2B). Choroidal neovascular membranes and subretinal fibrosis (Fig. 10-4) can also occur. A posterior placoid chorioretinitis has been described in late latent syphilis.23a Vitreous opacities are common, and lens dislocation has been reported in many patients.
The most typical manifestation of congenital syphilis is bilateral interstitial keratitis, which appears later in life. A pigmentary retinitis and glaucoma can also occur as a result of congenital syphilitic keratouveitis.
The Argyll Robertson pupil and disc edema are most commonly seen in meningovascular syphilis, along with oculomotor palsies and other pupillary abnormalities. Later in the course of meningovascular syphilis, optic atrophy occurs. A complete Argyll Robertson pupil is rare in cases of general paresis, but, as with optic atrophy, is more common in cases of tabes dorsalis.
Diagnosis
The diagnosis of syphilis is based on the clinical history, physical examination, and laboratory tests. Although darkfield examination or immunofluorescent staining of mucocutaneous lesions can lead to the prompt diagnosis of primary, secondary, and early congenital syphilis, most physicians order serologic tests to make or confirm a diagnosis. There are both nontreponemal and treponemal tests. Confusion often arises in determining whether a VDRL test should be ordered rather than an FTA-ABS test, and in the interpretation of the results. In this section the various diagnostic tests for syphilis are explained, and a strategy for ordering tests is outlined (Box 10-2).
Darkfield microscopy can be used to identify spirochetes present in tissue fluids. T. pallidum is difficult to distinguish from other spirochetes, and so darkfield examination requires expertise. In clinical practice, greater reliance is placed on the serologic test for syphilis.
The two most commonly used screening tests for syphilis are the VDRL test and the rapid plasma reagin (RPR) test. Both of these are nontreponemal reaginic tests. Infection with T. pallidum stimulates nonspecific antibodies against
145
Part 4 • Infectious Uveitic Conditions
Chapter 10 Spirochetal Diseases
A B
Figure 10-2. Fundus photograph of a patient with uveitis associated with syphilis. A shows a dense vitritis obscuring the optic disc and retinal vasculature. B shows the same patient following treatment with intravenous penicillin. The vitritis and retinal infiltrates have resolved, revealing the pigmentary retinopathy characteristic of ocular syphilis.
Figure 10-3. A, Patient with acquired syphilis who presented with papillitis and retinitis. B, The findings resolved following treatment with intravenous antibiotics. (Courtesy Phuc Le Hoang, MD.)
Box 10-2 Diagnosis of syphilis – key points
•Diagnosis is based on clinical history, physical examination, and laboratory tests
•There are both nontreponemal and treponemal tests for syphilis
•Nontreponemal tests are often used to screen for syphilis. The two most common screening tests are the Venereal Disease Research Laboratory (VDRL) test and the rapid plasma reagin (RPR) test
•Treponemal tests are more sensitive in diagnosing patients with latent or late syphilis and more specific than the VDRL. The most commonly used treponemal test is the fluorescent treponemal antibody absorption (FTA-ABS) test
Figure 10-4. Extensive subretinal fibrosis caused by ocular syphilis. (Courtesy Rubens Belfort Jr, MD.)
cardiolipin. The VDRL test quantitates these antibodies by use of slide flocculation. The VDRL test is well standardized, and the result is reported as reactive, weakly reactive, borderline, or nonreactive. The rapid plasma reagin test is a similar assay for detecting anticardiolipin antibody.
The sensitivity and the specificity of the VDRL test vary, depending on the stage of disease (Table 10-2). The VDRL test starts to become positive about 1–2 weeks after the appearance of the primary chancre and is positive in 99% of patients with secondary syphilis.24 In later stages of the disease, however, the VDRL test reactivity decreases, and only about 70% of patients with cardiovascular syphilis or neurosyphilis have a positive VDRL test result. In addition, the VDRL test often becomes nonreactive after treatment for syphilis.
The serologic tests for syphilis are not 100% specific, and false-positive results can occur, especially in patients with other spirochetal diseases and connective tissue diseases (Table 10-3). Any weakly reactive or reactive VDRL test needs to be confirmed with a more specific test. The tests used for this purpose are the treponemal tests for syphilis, such as the T. pallidum agglutination tests (TPHA and MHA-TP) or the more commonly used FTA-ABS test. The T. pallidum immobilization test is almost completely specific for syphilis, but is expensive and difficult to perform and therefore rarely used. The microhemagglutination–T. pallidum (MHA-TP) assay for antibodies to T. pallidum is another specific test for syphilis but is also used less frequently than the FTA-ABS test. In the FTA-ABS test, the patient’s serum is absorbed with extracts of nonpathogenic treponemes to remove possible
146
Table 10-2 Patients with positive results to VDRL and FTA-ABS tests Percentage of patients with positive results
Late or latent syphilis
Test
|
Primary |
Secondary |
Treated |
Untreated |
|
syphilis |
syphilis |
disease |
disease |
|
|
|
|
|
VDRL |
70 |
99 |
1 |
70 |
|
|
|
|
|
FTA-ABS |
85 |
100 |
98 |
98 |
|
|
|
|
|
VDRL, Venereal Disease Research Laboratory; FTA-ABS, fluorescent treponemal antibody absorption.
Table 10-3 Causes of false-positive serologic test results for syphilis
SPIROCHETAL INFECTIONS
Endemic syphilis (bejel)
Yaws and pinta
Leptospirosis
Lyme disease
Relapsing fever
OTHER INFECTIONS
Chancroid
Chickenpox
Hepatitis
HIV infection
Infectious mononucleosis
Leprosy
Lymphogranuloma venereum
Malaria
Measles
Mycoplasma pneumonia
Pneumococcal pneumonia
Rickettsial disease
Scarlet fever
Subacute bacterial endocarditis
Tuberculosis
Trypanosomiasis
NONINFECTIOUS CAUSES
Blood transfusions
Chronic liver disease
Connective tissue disease
Narcotic addiction
Pregnancy
Vaccination
cross-reacting antitreponemal antibody that is not specific for T. pallidum. The absorbed serum is then made to react against T. pallidum, and specific antibodies are detected by the addition of fluorescein-labeled antihuman γ-globulin. Results are reported as nonreactive or as 1+ to 4+ positive, based on the intensity of the fluorescence.
A weakly reactive FTA-ABS test may not be reproducible. The FTA-ABS test is more sensitive than the VDRL test at all stages of syphilis, but it is more expensive and difficult to perform. The FTA-ABS test is also not entirely specific for syphilis, because false-positive results are seen in patients with systemic lupus erythematosus, biliary cirrhosis, and some connective tissue diseases, such as rheumatoid arthritis (see Table 10-3).
Because serologic tests for syphilis may take several weeks to become reactive, immediate diagnosis requires
Spirochetes
demonstration of treponemes in tissue fluid by darkfield microscopy. The VDRL test is an excellent screening test for patients with later primary syphilis and secondary syphilis. The sensitivity of the VDRL test is 99% for patients with secondary syphilis; however, all positive results should be confirmed with an FTA-ABS test.
Because the sensitivity of the VDRL test may be only 70% in patients with latent or late syphilis, both VDRL and FTA-ABS tests should be ordered if a later stage of disease is suspected. From the ophthalmic standpoint, many patients with uveitis or disc edema are suspected of having late syphilis, and many uveitis specialists and neuro-ophthalmologists routinely order both VDRL and FTA-ABS tests in the evaluation of these patients. As stated above, in the United States, testing for syphilis has consisted of initial screening with an inexpensive nontreponemal test, with subsequent testing of reactive specimens with a treponemal test. Some clinical laboratories have started using automated treponemal tests and then retest reactive results with a nontreponemal test.24a It is not clear what the recommendations are for patients who test positive with the treponemal test and then negative for the nontreponemal test. If not previously treated, these patients should probably be treated for late latent syphilis.
In addition, all patients who may have had syphilis for more than a year should have a lumbar puncture for CSF examination. A cell count, differential count, protein determination, and VDRL test should be performed on the CSF to look for evidence of neurosyphilis. As stated previously, CNS invasion by T. pallidum may be common in early syphilis.15 The finding of CNS involvement is important because the recommended therapy is different from that for patients without CNS involvement. Serologic tests for neurosyphilis can also be confusing. The CSF-VDRL is insensitive but highly specific. A CSF serologic diagnosis is usually based on production of local antitreponemal antibodies, and an intrathecal T. pallidum antibody index can be calculated.
Infants born with congenital syphilis have positive VDRL and FTA-ABS test results from the passive transfer of immunoglobulin (Ig) G antibodies across the placenta; therefore, an IgM FTA-ABS test is used to diagnose congenital syphilis because IgM antibodies do not cross the placenta, and a positive test result would indicate actual infection in the infant.25
Patients with undiagnosed interstitial keratitis should be suspected of having late congenital syphilis. A thorough history of previous therapy should be elicited, and patients should then undergo VDRL and FTA-ABS tests and a CSF examination. If the CSF VDRL test result is positive, some experts recommend that the patient be treated as for latent syphilis (Table 10-4). Patients with a positive serum VDRL or FTA-ABS result but negative CSF findings are treated as for primary or secondary syphilis.
Finally, newer diagnostic techniques may be helpful in diagnosing syphilis in patients with ocular manifestations of syphilis. The polymerase chain reaction (PCR) may be used to detect T. pallidum in ocular specimens such as aqueous humor.
Prognosis
Most patients recover without long-term sequelae if syphilis is recognized and treated early. If untreated, about 25% of
147
- #28.03.202681.2 Mб0Ultrasonography of the Eye and Orbit 2nd edition_Coleman, Silverman, Lizzi_2006.pdb
- #
- #
- #
- #28.03.202621.35 Mб0Uveitis Fundamentals and Clinical Practice 4th edition_Nussenblatt, Whitcup_2010.chm
- #
- #
- #28.03.202627.87 Mб0Vaughan & Asbury's General Ophthalmology 17th edition_Riordan-Eva, Whitcher_2007.chm
- #
- #
- #
